Retained Earnings
Gilead Sciences Retained Earnings increased by 2.9% to $14.13B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.3%, from $10.93B to $14.13B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows relatively stable performance with a -0.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
A steady increase signals consistent profitability and effective capital reinvestment, whereas a decrease may indicate net losses or significant dividend payouts.
Detailed definition
This represents the cumulative net income earned by the company since its inception, minus any dividends paid to shareho...
Peer comparison
A key metric for mature biopharma companies, reflecting their long-term success in commercializing therapies and managing costs.
retained_earningsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.39B | $16.90B | $16.32B | $14.99B | $15.12B | $15.76B | $15.69B | $15.22B | $15.14B | $16.00B | $16.30B | $10.66B | $11.17B | $11.07B | $11.50B | $10.93B | $11.33B | $12.83B | $13.73B | $14.13B |
| QoQ Change | — | +9.8% | -3.4% | -8.2% | +0.9% | +4.2% | -0.4% | -3.0% | -0.6% | +5.7% | +1.9% | -34.6% | +4.8% | -0.8% | +3.8% | -4.9% | +3.6% | +13.2% | +7.1% | +2.9% |
| YoY Change | — | — | — | — | -1.8% | -6.8% | -3.9% | +1.6% | +0.1% | +1.6% | +3.9% | -30.0% | -26.2% | -30.8% | -29.5% | +2.6% | +1.4% | +15.8% | +19.4% | +29.3% |
Retained Earnings at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's retained earnings?
- Gilead Sciences (GILD) reported retained earnings of $14.13B in Q1 2026.
- How has Gilead Sciences's retained earnings changed year-over-year?
- Gilead Sciences's retained earnings increased by 29.3% year-over-year, from $10.93B to $14.13B.
- What is the long-term trend for Gilead Sciences's retained earnings?
- Over 5 years (2020 to 2025), Gilead Sciences's retained earnings has grown at a -0.9% compound annual growth rate (CAGR), from $14.38B to $13.73B.
- What does retained earnings mean?
- The total profits the company has kept and reinvested since it started, after paying out any dividends.